# Multi-centre, Open-label, First-in-man Study With Mucopad HA

> **NCT06276270** · NA · COMPLETED · sponsor: **Contipro Pharma a.s.** · enrollment: 50 (actual)

## Conditions studied

- Oral Mucositis

## Interventions

- **DEVICE:** Mucopad HA

## Key facts

- **NCT ID:** NCT06276270
- **Lead sponsor:** Contipro Pharma a.s.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-12
- **Primary completion:** 2024-11-30
- **Final completion:** 2024-11-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06276270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06276270, "Multi-centre, Open-label, First-in-man Study With Mucopad HA". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06276270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*